To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04234048
Title Phase 1 Trial of ST-001 NanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SciTech Development, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona RECRUITING Scottsdale Arizona 85259 United States Details
City of Hope Medical Foundation RECRUITING Duarte California 91010 United States Details
University of Southern California RECRUITING Los Angeles California 90007 United States Details
University of Colorado Anschutz Medical Campus RECRUITING Aurora Colorado 80045 United States Details
University of Michigan RECRUITING Ann Arbor Michigan 48109 United States Details
Barbara Ann Karmanos Cancer Institute Wayne State University RECRUITING Detroit Michigan 48201 United States Details
Columbia University RECRUITING New York New York 10032 United States Details
University of Pittsburgh Medical Center (UPMC) RECRUITING Pittsburgh Pennsylvania 15219 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field